title: Treatment of type II gastric carcinoid tumors with somatostatin analogues.
authors.affiliation: Department of Internal Medicine and Gastroenterology, University of Bologna, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Tomassetti
authors.forename: M
authors.initials: M
authors.lastname: Migliori
authors.forename: G C
authors.initials: GC
authors.lastname: Caletti
authors.forename: P
authors.initials: P
authors.lastname: Fusaroli
authors.forename: R
authors.initials: R
authors.lastname: Corinaldesi
authors.forename: L
authors.initials: L
authors.lastname: Gullo
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005755:Gastrins / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000150:complications; D015282:Octreotide / Q000627:therapeutic use*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000209:etiology; D015043:Zollinger-Ellison Syndrome / Q000150:complications
chemical_list: D000970:Antineoplastic Agents; D005755:Gastrins; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide